1. Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues
- Author
-
Peter Brown, David H. Drewry, Michael Foley, Chambers Cl, Frank Brown, Gregson M, Andrew B. McElroy, David N. Deaton, Davies Hg, and Bickett Dm
- Subjects
Indoles ,Stereochemistry ,Matrix metalloproteinase inhibitor ,Molecular Sequence Data ,Substituent ,Isoindoles ,Matrix Metalloproteinase Inhibitors ,chemistry.chemical_compound ,Structure-Activity Relationship ,Drug Stability ,Drug Discovery ,Side chain ,medicine ,Humans ,Ethyl group ,Amino Acid Sequence ,Imide ,Fluorescent Dyes ,Dipeptide ,Molecular Structure ,Metalloendopeptidases ,Dipeptides ,Hydrogen-Ion Concentration ,Ligand (biochemistry) ,Extracellular Matrix ,Zinc ,chemistry ,Chromogenic Compounds ,Gelatinases ,Collagenase ,Molecular Medicine ,Matrix Metalloproteinase 3 ,medicine.drug ,Half-Life - Abstract
Systematic modification of the presumed P1 side chain in a series of (carboxyalkyl)amino-based inhibitors of matrix metalloproteinases enabled identification of the 2-(1,3-dihydro-1,3-dioxo-2H-benz [f]isoindol-2-yl)ethyl group as a preferred substituent imparting potent inhibition of the enzymes collagenase and gelatinase. It was subsequently found that the P2'-P3' residues in this series could be replaced by small non-peptide residues, while maintaining inhibitory potency. The imide group in this series of compounds can undergo autocatalytic hydrolysis under neutral conditions
- Published
- 1994